Safety and pharmacodynamics of a novel recombinant botulinum toxin E (rBoNT-E): Results of a phase 1 study in healthy male subjects compared with abobotulinumtoxinA (Dysport®)
- Resource Type
- Article
- Source
- In
Journal of the Neurological Sciences 15 December 2019 407 - Subject
- Language
- ISSN
- 0022-510X